Tata group launches `Feluda' test kits:
Times of India 10th Nov 2020
Tate Medical and Diagnostics (Tata MD) announced the commercial launch of Tata MDCHECK. a diagnostic gene-based testing wit kit for Covid 19. It is powered by 'Feluda', a CRISPR Cas-9 technology developed by leading research institute. CSIR-IGIB. The company claims a quicker, simpler, and cheaper process as against the other technology. RT-PCR (Reverse transcription polymerase chain reaction) — considered the gold standard method for Covid 19 testing.